Veracyte Inc (VCYT):企業の製品パイプライン分析

◆英語タイトル:Veracyte Inc (VCYT) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME73376PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Veracyte Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Veracyte Inc Company Overview
Veracyte Inc Company Snapshot
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc – Pipeline Analysis Overview
Veracyte Inc – Key Facts
Veracyte Inc – Major Products and Services
Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Overview
Afirma – Risk of Recurrence
Afirma – Risk of Recurrence Product Overview
Afirma – Thyroid Cancer Staging/ Prognosis Test
Afirma – Thyroid Cancer Staging/ Prognosis Test Product Overview
Afirma Xpression Atlas – Pulmonology
Afirma Xpression Atlas – Pulmonology Product Overview
BronchoGen Test
BronchoGen Test Product Overview
Disease Diagnosis Device
Disease Diagnosis Device Product Overview
Envisia – Disease Progression Test
Envisia – Disease Progression Test Product Overview
Envisia – Rx Response Test
Envisia – Rx Response Test Product Overview
Nasal Swab Classifier – Lung Cancer
Nasal Swab Classifier – Lung Cancer Product Overview
nCounter Dx LymphMark Assay
nCounter Dx LymphMark Assay Product Overview
nCounter FLEX Analysis System – Idiopathic Pulmonary Fibrosis Test
nCounter FLEX Analysis System – Idiopathic Pulmonary Fibrosis Test Product Overview
Percepta Atlas
Percepta Atlas Product Overview
Veracyte Inc – Key Competitors
Veracyte Inc – Key Employees
Veracyte Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Veracyte Inc, Recent Developments
Sep 11, 2020: Veracyte announces initiation of consensus study exploring medical utility of multiple breast cancer genomic tests
Dec 04, 2019: Veracyte signs agreement for NanoString’s diagnostics platform
Nov 02, 2019: Veracyte announces new data that advance understanding of genomic alterations targeted by precision medicine therapies for thyroid cancer
Oct 30, 2019: Veracyte announces new data characterizing genomic alterations in thyroid cancer to be presented at 89th Annual Meeting of the American Thyroid Association
Oct 22, 2019: Veracyte announces third quarter 2019 financial results and business progress
Oct 22, 2019: Veracyte announces new clinical data showing first-ever noninvasive nasal swab test can enable early lung cancer detection and diagnosis
Oct 21, 2019: Veracyte announces clinical data demonstrating clinical validity and utility of Percepta Classifier in Lung Cancer Diagnosis when bronchoscopy results are inconclusive
Oct 21, 2019: Veracyte announces new data demonstrating that Envisia Genomic Classifier improves IPF Diagnosis
Oct 07, 2019: Veracyte to announce new clinical data for first noninvasive Nasal Swab Test to target early lung cancer detection at CHEST Annual Meeting 2019
Sep 11, 2019: Veracyte announces publication of clinical and analytical validation data for Afirma Xpression Atlas
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc Pipeline Products by Equipment Type
Veracyte Inc Pipeline Products by Indication
Veracyte Inc, Key Facts
Veracyte Inc, Major Products and Services
Veracyte Inc Number of Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Summary by Development Stage
Afirma - Risk of Recurrence - Product Status
Afirma - Risk of Recurrence - Product Description
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Status
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Description
Afirma Xpression Atlas - Pulmonology - Product Status
Afirma Xpression Atlas - Pulmonology - Product Description
BronchoGen Test - Product Status
BronchoGen Test - Product Description
Disease Diagnosis Device - Product Status
Disease Diagnosis Device - Product Description
Envisia - Disease Progression Test - Product Status
Envisia - Disease Progression Test - Product Description
Envisia - Rx Response Test - Product Status
Envisia - Rx Response Test - Product Description
Nasal Swab Classifier - Lung Cancer - Product Status
Nasal Swab Classifier - Lung Cancer - Product Description
nCounter Dx LymphMark Assay - Product Status
nCounter Dx LymphMark Assay - Product Description
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Status
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Description
Percepta Atlas - Product Status
Percepta Atlas - Product Description
Veracyte Inc, Key Employees
Veracyte Inc, Other Locations
Veracyte Inc, Subsidiaries
Glossary

★海外企業調査レポート[Veracyte Inc (VCYT):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anadolu Hayat Emeklilik A.S.:企業の戦略・SWOT・財務情報
    Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Avara Pharmaceutical Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UNITIKA LTD.:企業の戦略・SWOT・財務分析
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nagase & Co Ltd (8012):企業の財務・戦略的SWOT分析
    Nagase & Co Ltd (8012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Petroleo Brasileiro S.A. (Petrobras):企業のM&A・事業提携・投資動向
    Petroleo Brasileiro S.A. (Petrobras) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Petroleo Brasileiro S.A. (Petrobras) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Professional Insurance Corp Zambia PLC:企業の戦略・SWOT・財務分析
    Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report Summary Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務分析
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GenePOC Inc-医療機器分野:企業M&A・提携分析
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a no …
  • CenterPoint Energy Inc (CNP):電力:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Compagnie de Saint-Gobain:企業のM&A・事業提携・投資動向
    Compagnie de Saint-Gobain - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compagnie de Saint-Gobain Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Hunter Douglas NV (HDG):企業の財務・戦略的SWOT分析
    Hunter Douglas NV (HDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • B. Braun Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Medical Inc (B. Braun), a subsidiary of B. Braun Melsungen AG, is a medical device company that provides infusion therapy and pain management technology, products and services. The company’s product portfolio includes TPN compounding bags, parenteral nutrition additives, closed syst …
  • Lucigen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • SOCO International plc (SIA):企業の財務・戦略的SWOT分析
    Summary SOCO International Plc (SOCO) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. SOCO produces and supplies natural resources. SOCO h …
  • Daxor Corp (DXR):企業の財務・戦略的SWOT分析
    Daxor Corp (DXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • FitLife Brands, Inc.:戦略・SWOT・企業財務分析
    FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communit …
  • Keysight Technologies Inc:企業の戦略・SWOT・財務分析
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆